Clinical Drug Experience Knowledgebase

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Colorectal Neoplasms (Phase 3)

Enteropathy-Associated T-Cell Lymphoma (Phase 2)

Glioma (Phase 2)

Immunoblastic Lymphadenopathy (Phase 2)

Leukemia (Phase 2)

Leukemia, Large Granular Lymphocytic (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Prolymphocytic (Phase 2)

Leukemia, Prolymphocytic, B-Cell (Phase 2)

Leukemia, Prolymphocytic, T-Cell (Phase 2)

Lymphoma (Phase 2)

Lymphoma, Extranodal NK-T-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Pancreatic Neoplasms (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Stomach Neoplasms (Phase 2)